Article 2 Amendment of article 4 of the principal Order
In article 4 of the principal Order (medicinal products that are not prescription only)—
(a)
in paragraph (1C) (mebendazole) for “400 milligrams” substitute “800 milligrams”;
(b)
in paragraph (1N) (famotidine) for sub-paragraph (a) there is substituted the following sub-paragraph—
“(a)the medicinal product is indicated for—
(i)the short-term symptomatic relief of heartburn, dyspepsia, indigestion, acid indigestion or hyperacidity, or
(ii)the prevention of the symptoms of heartburn, dyspepsia, indigestion, acid indigestion or hyperacidity where they are associated with the consumption of food or drink, including the prevention of sleep disturbance due to those symptoms, and”.